Detalhe da pesquisa
1.
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
Cancer
; 129(23): 3772-3782, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769113
2.
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Oncologist
; 2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536733
3.
Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib.
Cancer Genet
; 260-261: 46-52, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929613
4.
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.
JCO Precis Oncol
; 6: e2100418, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085007
5.
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
Eur J Endocrinol
; 186(6): 631-643, 2022 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35333737
6.
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.
Neuro Oncol
; 24(6): 997-1007, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850167